The influence of GLP-1 receptor agonist on the heart rate using holter electrocardiography and power spectrum analysis on heart rate variability
Phase of Trial: Phase II
Latest Information Update: 09 Jun 2015
At a glance
- Drugs Liraglutide (Primary) ; Lixisenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 09 Jun 2015 Primary endpoint (24h-heart rate for Liraglutide) has been met as per abstract published at 75th Annual Scientific Sessions of the American Diabetes Association.
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 06 Jun 2015 New trial record